>
ProQinaseProQinase
ProQinase公司創(chuàng)立于2001年,是Tumor Biology Center Freiburg的子公司,專注于提供開發(fā)腫瘤相關(guān)蛋白激酶藥物的產(chǎn)品和服務(wù)。
ProQinase GmbH was founded in 2001 as a subsidiary of the Tumor Biology Center Freiburg. This cancer center combined excellent research with exceptional patient care under one roof. Initially, ProQinase was established in order to support funding of the Tumor Biology Center′s in-house anti-cancer drug development by marketing research tools and test systems. Today, ProQinase is a leading contract research organization (CRO) for drug discovery in oncology.
Since 2015 ProQinase belongs to a Chinese private equity fund. The company has about 40 employees and is located in Freiburg in the south-west of Germany. The labs and offices in Freiburg are complemented by a storage site in the Boston area, USA.
Our vision is to develop the company into a world class CRO for Integrated Drug Discovery (IDD) in oncology.
產(chǎn)品列表:
No. |
品牌 |
貨號(hào) |
名稱 |
規(guī)格 |
1 |
ProQinase |
0924-0000-1 |
ABL1 E255K |
10 μg |
2 |
ProQinase |
1202-0000-1 |
PI4K2A |
10 μg |
3 |
ProQinase |
0134-0000-1 |
CDK1 |
10 μg |
4 |
ProQinase |
1211-0000-1 |
ELK1 |
100 μg |
5 |
ProQinase |
0181-0000-1 |
BRK |
10 μg |
6 |
ProQinase |
1161-1165-1 |
PIK3CA/PIK3R1 |
10 μg |
7 |
ProQinase |
0332-0000-1 |
DAPK1 |
10 μg |
8 |
ProQinase |
1163-0000-1 |
PIK3CG |
10 μg |
9 |
ProQinase |
0458-0000-2 |
JNK1 (non activated) |
10 μg |
10 |
ProQinase |
0785-0000-1 |
MEK1 K97M |
100 μg |
11 |
ProQinase |
0639-0000-1 |
p38-alpha (nonactivated) |
10 μg |
12 |
ProQinase |
0590-0000-1 |
RBER-CDC25tide |
100 μg |
13 |
ProQinase |
0958-0000-2 |
p38-gamma (non activated) |
10 μg |
14 |
ProQinase |
0349-0000-5 |
RBER-GSK3(14-27) |
100 μg |
15 |
ProQinase |
1241-0000-1 |
PKC-zeta aa184-592 K281M |
10 μg |